Recognized globally for over two decades of innovation, leadership, and contributions to software engineering, Rupenkumar ...

As the president and CEO of COTA Healthcare, Sasu is working to solve a core problem in the industry: "how to use data to ...

The age of artificial intelligence (AI) has transformed our interactions, but threatens human dignity on a worldwide scale, ...

AI-generated papers are on the rise, and concerns grow around authorship, AI plagiarism, and maintaining trust in ...

Overview of Nanotechnology Drug Delivery MarketThe global Nanotechnology Drug Delivery Market is valued at USD 97.98 Billion ...

In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with ⁠Ana Pedro Jesuíno⁠, global head local QPPV ...

Bold, New Federal Legislation Will Make Beauty & Personal Care Products Safer for All by Banning the Worst Toxic Chemicals, ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Companies that master basic data governance will be best positioned to extract true value from their information assets while minimizing costs and risks.